Bahl and Gaynor Small Cap Dividend ETF (SCDV)
Live price chart, market sentiment, and community perspectives for Bahl and Gaynor Small Cap Dividend ETF (AMEX: SCDV).
Live price chart, market sentiment, and community perspectives for Bahl and Gaynor Small Cap Dividend ETF (AMEX: SCDV).
Watching the 50-day simple moving average at $27.06 and the 200-day moving average at $26.40, our desk notes that SCDV has maintained a tight range with a 52-week high around $28.04 to $28.52. Market sentiment remains cautiously optimistic given its 0.72 beta, pointing to a resilient small-cap blend profile that attracts defensive equity allocations.
When evaluating active small-cap dividend strategies for portfolio integration, SCDV's lack of an index tracker means everything depends on Bahl and Gaynor's active management execution. With AUM sitting near $143M to $153M and a PE ratio around 26.87, analysts must weigh the fund's stated objective of downside protection against broader small-cap blend benchmarks.
On our risk management desk, we examined the recent surge in short interest for SCDV—which jumped by 100.8% in July to reach 3,301 shares. While this sounds dramatic, it represents just 0.1% of the total shares and reflects a tiny days-to-cover ratio of 0.5 days. Liquidity remains the primary constraint due to average volumes hovering near 7,000 to 10,000 shares.
Analyzing the fundamental metrics provided in the April 2026 prospectus and recent filings, SCDV operates with a distributing policy under an active equity structure. The total holdings count sits at 42 stocks, offering concentrated exposure rather than broad index replication, which requires close monitoring of individual portfolio allocations by institutional allocators.
From a macro sentiment standpoint, investors looking at SCDV are primarily drawn to its dual mandate of long-term growth of dividend income and total return. Recent weekly and monthly performance figures show positive momentum, with a recent price print around $27.31 to $27.64, outperforming some broader volatility concerns in the small-cap segment.
Explore plasma cleansing, somatic organ swaps, and BCI.